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AAA Rupture Often Occurs Outside the Maximal Diameter Region
and is Preceded by Rapid Local Growth and an Increased
Biomechanical Rupture Risk Index
A. Siika, M.L. Liljeqvist, R. Hultgren, C. Gasser, J. Roy
Karolinska Institutet, Stockholm, Sweden
Introduction: Rupture risk prediction of abdominal aortic aneurysms (AAA)
relies on maximal diameter (Dmax) measurements. If Dmax exceeds 55 mm
aortic surgery is considered beneﬁcial. However, even small aneurysms
rupture while some large aneurysms never rupture. Our objective was to
study the size and location of ruptures in AA patients in our center and to
relate the location and growth of the local rupture site to the Dmax.
Furthermore, we studied whether the biomechanical rupture risk esti-
mated using ﬁnite element analysis (FEA) could predict rupture.
Methods: All patients diagnosed with AAA rupture (treated or not
treated) in our catchment area during the years 2009e2013 were included.
50 patients had undergone high quality computed tomography angiog-
raphy examination. Dmax, orthogonally to the centerline, local diameter at
the rupture site and its distance from the Dmax region was recorded. 14
patients had a previous CTA conducted within 2 years prior to AAA rupture.
FEA was performed and Peak wall stress (PWS) and Peak wall rupture index
(PWRI ¼ maximal wall stress/wall strength ratio) were calculated using A4
Clinics software (VASCOPS, Austria).
Results: Themedian diameter at rupture was 77mm.Two rAAAs (4%) had
aDmax<55mmandﬁve (10%)had aDmax<60mm. 50%of the30 identiﬁed
rupture sites were located outside the Dmax region. In the 14 patients with a
pre-rupture CTA, PWRI was signiﬁcantly higher than in the control group
(0.41 vs. 0.34, p ¼ 0.005) but no signiﬁcant differences in PWS (212 vs.
197 kPa, p ¼ 0.20) or maximal diameter (61 vs. 58 mm, p ¼ 0.23) were
detected. Diameter growth rate between the pre-rupture and rupture CTs
was in 67% of the cases higher in the rupture region than in the Dmax region.
Conclusion: In this cohort of all consecutive rAAA patients (treated and
not treated), a signiﬁcant number of ruptured aneurysms had small di-
ameters at rupture. Ruptures often occurred outside the maximal diameter
area, sometimes in segments with a relatively small local diameter. In the
small cohort of rupture patients with a pre-rupture CTA, FEA could predict
AAA rupture. In addition, rupture sites were preceded by rapid local growth.
Our results support the notion of considering the entire geometry of an
aneurysm, rather than sole reliance on maximum diameter measurements.
Comparison of Renal Outcomes in Matched Cohorts Treated by
Zenith Fenestrated and Zenith AAA Stent Grafts in US
Prospective Pivotal Trials
L.R. de Souza, G.S. Oderich, S. Textor, M.A. Farber, S. Haulon,
P. Banga, P. Gloviczki, F. Jia
Vascular and Endovascular Surgery Division, Mayo Clinic, Rochester, MN, USA
Introduction: Fenestrated endovascular repair (FEVAR) has been increasingly
utilized to treat complex abdominal aortic aneurysms (AAAs). The added riskE-mail address: esvs.secretary@btconnect.com (S. Parvin).
1078-5884/$ e see front matterof renal function deterioration as compared to patients undergoing infra-
renal endovascular aortic repair (EVAR) has not yet been determined.
Methods: Patients with preserved renal function (eGFR  45 ml/min)
enrolled in two prospective, non-randomized pivotal studies evaluating the
Zenith fenestrated and Zenith AAA stent grafts (Cook Medical Inc.,
Bloomington IN) were matched (1:2) by propensity scores for age, gender,
hypertension, diabetes, and pre-operative eGFR. There were 67 patients
treated by FEVAR and 134 matched controls treated by EVAR. Mean follow
up was 30  20 months. Renal outcomes included acute kidney injuries
deﬁned by RIFLE criteria (Risk, Injury, Failure, Loss, End-stage) and changes
in sCr, eGFR, and CKD staging up to 5 years. Renal duplex ultrasound follow
up was obtained only in the FEVAR group.
Results: Acute kidney injury at one month were similar between
groups with >50% decline in eGFR observed in 6% of FEVAR and 11% of
EVAR patients (P ¼ 0.68). There were no signiﬁcant differences in >25%
decline in eGFR at 2-years (20% vs. 20%; P ¼ 0.99) and 5 years (27% vs.
50%, P ¼ 0.50) between patients treated by FEVAR or EVAR, respectively.
Progression to stage IV-V CKD was similar at 2-years (2% vs. 3%; P ¼ 0.99)
and 5 years (7% vs. 8%, P ¼ 0.94) in the FEVAR and EVAR groups, with
similar sCr and eGFR values up to 5 years. During follow up, there were
more renal artery stenosis/occlusions (15/67 vs. 3/134, P < 0.001) and
more renal related re-interventions (12/67 vs. 4/134, p < 0.001) in pa-
tients treated by FEVAR compared to EVAR, respectively. However, rate of
progression to renal failure requiring dialysis was low and identical in both
groups (1.4% vs. 1.4%, P ¼ 0.99).
Conclusion: Endovascular aortic repair with fenestrated and infra-renal
AAA stent grafts was associated with similar rates of renal function
deterioration in patients who initially had preserved renal function. Renal-
related re-interventions were higher following FEVAR, although net
changes in renal function were similar in both groups. Surveillance of renal
artery alignment stents is recommended to detect stenosis or occlusion
after FEVAR. In patients with preserved renal function, the decision on
type of repair should be based upon anatomical factors such as length of
infra-renal aortic sealing zone and aneurysm involvement of the visceral
arteries, rather than impact on renal function status.
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Introduction: The Nellix Endovascular Aneurysm Sealing (EVAS) has been
proposed as an alternative to conventional endovascular aneurysm repair
in attempt to deal with the limitations of this method, speciﬁcally, endo-
leaks and migration. The aim of the study was to present our experience in
the treatment of patients with abdominal aortic aneurysms (AAA) with
challenging neck anatomy.
Methods: From January 2014 to April 2015, 50 patients (43 male, 7
female), aged 56e87, underwent implantation of Nellix stent graft for AAA.
In one case an emergency procedure was performed in a patient with
secondary aneurysm rupture due to bifurcated stent graft migration. The
procedures were performed under spinal (41) or general anesthesia (9).
Results: All procedures were completed without complications. In ﬁve
cases the procedure was performed beyond instruction for use. Four renal
Abstracts 391chimney Advanta V12 stent grafts were used (one unilateral and three
bilateral) from axillary access. In one case aorto-uniiliac Nellix was
implanted with cross-over by-pass. The decision was made during the
procedure when there was no possibility to introduce one of the stent
grafts due to tortuous and calciﬁed iliac artery. The mean length of hospital
stay was 6 days, four patients were sent to intensive care unit for one day
after the procedure. No endoleaks were noticed during the procedure and
during follow up. All prostheses remain patent. One patient was readmitted
on 17th post-operative day due to secondary aneurysm rupture. Open
conversion was performed, the Nellix stent graft was explanted and
replaced with a bifurcated graft. Further follow up was uneventful.
Conclusion: EVAS is an innovate concept in the treatment of AAA
designed to target the causes of secondary interventions such as endo-
leaks and migration. It offers an alternative for patients unsuitable for
fenestrated devices or open surgery. Results of the chimney technique,
though beyond the instruction for use for the procedure, are very
promising and in particular cases it can be an alternative to custom made
fenestrated stent grafts reducing costs and shortening the time of waiting
for interventions.
Aorto-Enteric Fistula following Endovascular Aortic Repair:
Results from the Multicenter study on Aorto-Enteric FIstulization
after STent grafting Of the abdominal aorta (MAEFISTO)
A. Kahlberg, E. Rinaldi, P. Castelli, G. Piffaretti, F. Speziale,
P. Sirignano, S. Trimarchi, S. Segreti, E. Costantini, B. Campanati,
S. Bonardelli, E. Cervi, V. Baratta, S. Aiello, A. Sarcina, R. Bellosta,
G. Melissano, R. Chiesa
Vascular Surgery, Vita-Salute University School of Medicine, San Raffaele
Scientiﬁc Institute, Milano, Italy
Introduction: As the number of patients treated with endovascular
abdominal aortic repair (EVAR) is considerably growing in recent years,
related complications are observed with increasing frequency. Among
these, aortoenteric ﬁstula (AEF) is known to be a dramatic and highly lethal
event, but evidence in the literature is scant and mainly based on single
center case reports. Aim of this study is to investigate the incidence, clinical
features, therapeutic options, and outcomes of AEF developing after EVAR.
Methods: A retrospective multicenter study was conducted among
eight Italian universities and hospital centers with an abdominal aortic
endovascular program, to collect data on AEF developed after EVAR per-
formed for non-infectious disease.
Results: Among 3,932 patients who underwent EVAR between 1997 and
2013, 32 (0.8%; 27 males, mean age 72  8 years) developed an AEF.
Median time between EVAR and AEF formation was 18.5 months (inter-
quartile range, IQR: 10.5e63.5 months). Both anastomotic pseudoaneur-
ysm as the indication to EVAR, and urgent/emergent EVAR resulted
signiﬁcantly associated with AEF development (34% vs. 5%, P < 0.0001;
and 22% vs. 8%, P ¼ 0.01; respectively). Among 5 patients treated
conservatively, 2 (40%) died at 7 and 15 months respectively, while the
other 3 are alive at a median follow up of 12 months (IQR: 7e15). The
remaining 27 patients underwent AEF surgical treatment, with a peri-
operative mortality of 37% (n ¼ 10). No additional aortic related death was
recorded in operated patients at a median follow up of 28 months (IQR:
14e42).
Conclusion: Late AEF may occur in less than 1% of patients submitted to
EVAR, with an increased risk in case of emergent EVAR or performed for
pseudoaneurysm following previous aortic surgery. Both conservative and
surgical treatment of post-EVAR AEF is associated with high mortality.
However, beyond the peri-operative period, surgical correction of AEF
appears to be durable at mid-term follow up.
Internal Iliac Aneurysms have a Low Risk of Rupture under 4 cm:
A Multicentre Study
M.T. Laine, M. Björck, B. Beiles, M. Altreuter, Z. Szeberin, I. Thompson,
S. Debus, K. Mani, G. Menyhei, M. Venermo
Helsinki University Hospital, Helsinki, FinlandIntroduction: Internal iliac artery aneurysms are rare and their risk of
rupture is unknown. The deﬁnition of common iliac aneurysm is a
maximum diameter of greater than 18e20 mm, but there is no clear
diameter deﬁnition for internal iliac aneurysms. The threshold for elective
repair in iliac aneurysms is commonly 30 mm. However, no strong scientiﬁc
data exists on the risk of rupture. The aim of the current study was to
evaluate the size of internal iliac aneurysm at the time of rupture.
Methods: This was a retrospective multicentre study including patients
with ruptured internal iliac artery aneurysm (RIIAA) from Australia, Finland,
Germany, Hungary, New Zealand, Norway and Sweden. The data on
aneurysm size at the time of rupture, information on concomitant aneu-
rysms in aorta, ipsilateral common iliac artery as well as contralateral iliac
arteries, treatment of the RIIAA as well as outcome were collected from CT-
images and patients’ case records.
Results: In total 59 RIIAA patients were treated during 2004e2014.
Median diameter at the time of rupture was 67.5 mm (IQR 52e85 mm,
range 25 e116 mm). In one patient (1.8%) the maximum diameter was less
than 3 cm, in 3 patients (5.5%) less than 4 cm. Mean age at the time of
rupture was 77 years. 86% of patients were men. 57% had bilateral IIAA,
64% also had an aneurysmal common iliac artery and 44% also had AAA.
38% had involvement of internal and common iliac arteries and the aorta.
29% had an isolated internal iliac aneurysm. Repair by either open pro-
cedure (n ¼ 42, 71%), endovascular procedure (n ¼ 12, 20%) or hybrid
procedure (n ¼ 5, 8.5%) was performed on all patients. 30 day mortality
was 19%; 8.3% after endovascular treatment, 21% after open surgery and
20% after a hybrid procedure.
Conclusion: Internal iliac artery aneurysm ruptures are rare. As with
RAAA most of the patients are male. Compared to operative RAAA
mortality, RIIAA mortality seems to be somewhat lower with less than 20
% mortality at 30 days. The median size of the aneurysm at the time of
rupture was 67 mm, compared to 76 mm in abdominal aortic aneurysms.
Only one patient had a rupture at a diameter of less than 3 cm, which
suggests that the threshold for elective treatment might be quite safely
increased to 4 cm.
Comparative Effectiveness of Endovascular versus Open Repair
for Juxta- and Suprarenal Abdominal Aortic Aneurysms
K.H.J. Ultee, BSc, S.L. Zettervall, MD, P.A. Soden, MD, J. Darling, BA,
H.J.M. Verhagen, MD, PhD, M.L. Schermerhorn, MD
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
Introduction: With the advancement of endovascular techniques (EVAR)
for abdominal aortic aneurysm repair (AAA), the number of patients
treated for juxta- and suprarenal aneurysms with EVAR is increasing. During
the adoption of new treatment strategies, it is important to track perfor-
mances and compare results to conventional treatment. The purpose of
this study was, therefore, to examine perioperative outcomes in patients
undergoing endovascular juxta- and suprarenal AAA repair and compare
those results to conventional open repair.
Methods: We identiﬁed all patients undergoing non-emergent EVAR or
open repair for juxta- and suprarenal AAA between January 2003 and
December 2014 in the Targeted Vascular data set from the American
College of Surgeons National Surgical Quality Improvement Program.
Comparative analyses included patient and intraoperative characteristics,
in addition to 30-day postoperative outcomes. Independent risk factors for
morbidity and mortality were established using multivariable logistic
regression analysis.
Results: A total of 907 patients were included, with 411 (45%) un-
dergoing EVAR, and 496 (55%) undergoing open repair. Perioperative
mortality following EVAR was 2.2% vs. 4.6% after open repair
(P ¼ .047). Postoperative deterioration of renal function was less
common among patients undergoing EVAR (2.2% vs. 8.7%, P < .001), as
well as the need for dialysis (1.2% and 5.2%, P ¼ .001). Other differ-
ences in perioperative morbidity after EVAR and open repair, respec-
tively, included the occurrence of ischemic colitis (1.0% vs. 5.0%,
P < .001), myocardial infarction (0.7% vs. 3.8%, P ¼ .002), wound
dehiscence (0.2% vs. 2.6%, P ¼ .005), pneumonia (1.2% vs. 7.9%,
P < .001), prolonged ventilator dependence (1.9% vs. 13.5%, P < .001)
